External validity of first‐trimester algorithms in the prediction of pre‐eclampsia disease severity

To compare disease features in women with pre‐eclampsia between those who are correctly identified (true positive) and those who are missed (false negative) when applying first‐trimester prediction algorithms for pre‐eclampsia to a prospectively enrolled population.

[1]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[2]  L. Magder,et al.  Prediction of preeclampsia utilizing the first trimester screening examination. , 2014, American Journal of Obstetrics and Gynecology.

[3]  A. Baschat,et al.  First‐trimester prediction of pre‐eclampsia: external validity of algorithms in a prospectively enrolled cohort , 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  A. Baschat,et al.  First-Trimester Risk Factors for Preeclampsia Development in Women Initiating Aspirin by 16 Weeks of Gestation , 2014, Obstetrics and gynecology.

[5]  N. Arulkumaran,et al.  Severe pre-eclampsia and hypertensive crises. , 2013, Best practice & research. Clinical obstetrics & gynaecology.

[6]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[7]  H. Figueroa-Diesel,et al.  First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study , 2013, Prenatal diagnosis.

[8]  A. Franx,et al.  Maternal Characteristics, Mean Arterial Pressure and Serum Markers in Early Prediction of Preeclampsia , 2013, PloS one.

[9]  R. Rodrigo,et al.  Prediction of early and late pre‐eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[10]  E. Gratacós,et al.  Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. , 2013, American journal of obstetrics and gynecology.

[11]  K. Heimdal,et al.  Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[12]  W. Oyen,et al.  Co-occurrence of Cardiovascular and Prothrombotic Risk Factors in Women With a History of Preeclampsia , 2013, Obstetrics and gynecology.

[13]  Kypros H. Nicolaides,et al.  Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers , 2012, Fetal Diagnosis and Therapy.

[14]  Yves Giguère,et al.  Early Administration of Low-Dose Aspirin for the Prevention of Severe and Mild Preeclampsia: A Systematic Review and Meta-Analysis , 2012, American Journal of Perinatology.

[15]  B. Sibai.  Evaluation and management of severe preeclampsia before 34 weeks' gestation. , 2011, American journal of obstetrics and gynecology.

[16]  D. Nelson,et al.  First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. , 2011, Placenta.

[17]  A. Gruslin,et al.  Pre-eclampsia: fetal assessment and neonatal outcomes. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[18]  F. Figueras,et al.  Contemporary prediction of preeclampsia , 2011, Current opinion in obstetrics & gynecology.

[19]  Argyro Syngelaki,et al.  Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks , 2011, Prenatal diagnosis.

[20]  K. Nicolaides,et al.  Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling , 2011, Prenatal diagnosis.

[21]  F. Audibert,et al.  Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. , 2010, American journal of obstetrics and gynecology.

[22]  M. Tikkanen.  Etiology, clinical manifestations, and prediction of placental abruption , 2010, Acta obstetricia et gynecologica Scandinavica.

[23]  K. Nicolaides,et al.  Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks , 2010, Prenatal diagnosis.

[24]  I. Herraiz,et al.  Application of a first‐trimester prediction model for pre‐eclampsia based on uterine arteries and maternal history in high‐risk pregnancies , 2009, Prenatal diagnosis.

[25]  K. Nicolaides,et al.  Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[26]  K. Haram,et al.  The HELLP syndrome: Clinical issues and management. A Review , 2009, BMC pregnancy and childbirth.

[27]  J. Baxter,et al.  HELLP Syndrome: The State of the Art , 2004, Obstetrical & gynecological survey.

[28]  B. Sibai.  HIGH-RISK PREGNANCY SERIES: AN EXPERT’S VIEW Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count , 2004 .

[29]  J. Himes,et al.  1994–1996 U.S. Singleton Birth Weight Percentiles for Gestational Age by Race, Hispanic Origin, and Gender , 1999, Maternal and Child Health Journal.

[30]  A. Karmiloff-Smith.  Syndrome: The State of the Art , 2008 .

[31]  E. Bennett,et al.  The first trimester. , 1984, JOGN nursing; journal of obstetric, gynecologic, and neonatal nursing.